Theragen Etex KRX:066700KOSDAQ
테라젠이텍스 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, Theragen Etex reported revenue of ₩69.3bn, up 3.6% year on year, and operating profit of ₩2.6bn. Theragen Etex (테라젠이텍스) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Turnaround Screener
Theragen Etex quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩69.3bn | +3.6% | ₩2.6bn | −₩7.2bn |
| Q1 2026 | ₩68.5bn | +2.0% | ₩1.9bn | −₩3.4bn |
| Q4 2025 derived | ₩69.0bn | +5.3% | ₩4.2bn | ₩9.6bn |
| Q3 2025 | ₩68.6bn | +14.5% | ₩2.0bn | ₩3.8bn |
| Q2 2025 | ₩66.8bn | +8.8% | −₩476m | ₩793m |
| Q1 2025 | ₩67.2bn | +14.3% | ₩4.5bn | −₩2.5bn |
| Q4 2024 derived | ₩65.5bn | +8.0% | ₩2.4bn | −₩46.4bn |
| Q3 2024 | ₩59.9bn | +10.7% | ₩2.8bn | ₩3.7bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Theragen Etex top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Theragen Etex news Korean headlines
No articles yet.